Tokio Marine Capital to Sell Showa
Japanese buyout shop Tokio Marine Capital has hired Citigroup to advise on the sale of generic drug company Showa Yakuhin Kako Co., Reuters reported, citing a Basis Point report. Tokio Marine Capital led a consortium to buy the asset from JAFCO for around 40 billion yen in 2008, equivalent to around $400 million including debt at that time. The consortium included Polaris Capital Group and PineBridge Investments, Reuters wrote.





